Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SEI Medical PCLBKK:SEI -1.66%19 EBITDA Margin % is 14.94% as of Mar. 2026, which is 0% below its 10-year median of 14.99. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, SEI Medical PCL ranks better than 88.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. SEI Medical PCL's EBITDA for the
three
months ended in Mar. 2026 was ฿15.0 Mil. SEI Medical PCL's Revenue for the
three
months ended in Mar. 2026 was ฿100.2 Mil. Therefore, SEI Medical PCL's EBITDA margin for the quarter that ended in Mar. 2026 was 14.94%.
SEI Medical PCL (BKK:SEI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
SEI Medical PCL EBITDA Margin % Related Terms
SEI Medical PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for SEI Medical PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SEI vs MCK, CAH, COR: EBITDA Margin % Comparison
For the Medical Distribution subindustry, SEI Medical PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SEI Medical PCL EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SEI Medical PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where SEI Medical PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SEI Medical PCL (BKK:SEI) has a EBITDA Margin % of 14.94% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SEI Medical PCL and its competitors. This is near median its historical median of 14.99. Over the past decade, SEI Medical PCL's EBITDA Margin % has ranged from 11.59 to 18.47. According to the industry distribution chart, SEI Medical PCL ranks #13 out of 117 companies in the Medical Distribution industry, placing it in the top 11.1%.
Is SEI Medical PCL's EBITDA Margin % too high?
SEI Medical PCL's current EBITDA Margin % of 14.94% is near median its 10-year median of 14.99. Over the past 10 years, this metric has ranged from a low of 11.59 to a high of 18.47. The Medical Distribution industry median EBITDA Margin % is 4.20. SEI Medical PCL's value of 14.94% is 255.7% above this industry median. Based on the distribution chart, SEI Medical PCL ranks #13 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's EBITDA Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SEI Medical PCL ranks #13 out of 117 companies for EBITDA Margin %. This places SEI Medical PCL in the top 11% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.20. SEI Medical PCL's value of 14.94% is 255.7% above this benchmark. Historically, SEI Medical PCL's own EBITDA Margin % has ranged from 11.59 to 18.47 over the past decade. While the company's 10-year median is 14.99 vs. the industry median of 4.20, SEI Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.20, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SEI Medical PCL's current EBITDA Margin % of 14.94% is 255.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SEI Medical PCL and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SEI Medical PCL's current EBITDA Margin % is 14.94%, which is near median its own 10-year median of 14.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current EBITDA Margin % of 14.94%. The current EBITDA Margin % is 14.94%, which is near median its 10-year median of 14.99 and 255.7% above the Medical Distribution industry median of 4.20. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current EBITDA Margin % is 14.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score
Get the complete analysis for BKK:SEI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SEI has been successfully added to your 
